Kodi B (02487) announced that Kodi Biopharmaceuticals (Wuxi) Co., Ltd. (Kodi Wuxi), a wholly-owned subsidiary of the company, was issued a “Pharmaceutical Production License” by the Jiangsu Drug Administration.
Kodi Wuxi has now obtained a pharmaceutical production license, which is expected to have a long-term positive effect on the company's expansion of production capacity and market expansion, and lay the foundation for the subsequent commercialization of candidate products.